ESMO: Group 1A: Triple Negative Breast Cancer: Patient-Reported Outcomes & Quality of Life
The ESMO Congress 2026 is a leading global oncology event showcasing the latest advances in cancer research and treatment. GRASP provides a unique opportunity for advocates and clinical researchers to join the conversation through Poster Walkthroughs. Register Below This ESMO26 Poster Walkthrough group will explore key findings from the following posters: Poster #4659P: Association Between […]

